Joshua Silverman

Aromyx Corp. engages in the using of biological receptors from the human nose to create digital representations of smell sensory data for multiple application. Its products include EssenceChip, EssenceCapture, EssenceAnalytics, and EssenceCloud. The company was founded by Chris Hanson and is headquartered in Palo Alto, CA.

Windfall Bio, Inc. has developed a solution to capture and transform methane emissions into organic fertilizer. Windfall Bio was founded in 2022 and is based in Menlo Park, CA. This nature-based solution utilizes methane-eating microbes to convert methane from any source into valuable outputs. The company's solution helps reduce the carbon footprint of methane emitters in various industries, including agriculture, oil and gas, and waste management. It also allows farmers to improve profitability and environmental impact. The company is venture-backed by top-tier firms and is focused on naturally transforming methane into organic soil nutrients. Joshua Silverman has been the CEO of the company since 2023.

Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA.

Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA.

Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.

Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.